LANDOS BIOPHARMA INC (LABP) Stock Balance Sheet
USA - NASDAQ:LABP - US5150692011 - Common Stock
22.93 USD
+0.13 (+0.58%)
22.91 USD
-0.02 (-0.09%)
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 29.00M | 37.50M | 36.64M | 8.31M | 2.42M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | 0 | 7.76M | 82.58M | 25.72M | |||
| Receivables | null | null | null | null | 150.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 892.00K | 541.00K | 850.00K | 1.27M | 1.60M | |||
| Total Current Assets | 29.90M | 38.04M | 45.25M | 92.15M | 29.89M | |||
| Non-Current Assets | ||||||||
| PPE Net | null | null | 0 | 710.00K | 440.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | null | null | 0 | 30.00K | 0 | |||
| Total Non-Current Assets | 0 | 0 | 0 | 730.00K | 440.00K | |||
| TOTAL ASSETS | 29.90M | 38.04M | 45.25M | 92.88M | 30.33M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 5.18M | 4.87M | 2.69M | 3.70M | 1.94M | |||
| Accounts Payable | 1.56M | 1.38M | 3.44M | 12.91M | 8.61M | |||
| Other Current Liabilities | null | null | null | 0 | 490.00K | |||
| Total Current Liabilities | 6.74M | 6.25M | 6.12M | 16.61M | 11.03M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | 0 | 280.00K | |||
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 280.00K | |||
| TOTAL LIABILITIES | 6.74M | 6.25M | 6.12M | 16.61M | 11.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -164.26M | -155.36M | -133.43M | -94.15M | -55.73M | |||
| Additional Paid In Capital | 187.38M | 187.12M | 172.21M | 170.24M | 1.63M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 31.00K | 31.00K | 400.00K | 400.00K | 73.11M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | 0 | -60.00K | -230.00K | 10.00K | |||
| Shares Outstanding | 3.12M | 3.12M | 4.03M | 4.03M | 4.01M | |||
| Tangible Book Value per Share | 7.42894 | 10.20011 | 9.7097 | 18.9256 | -13.4713 | |||
| Total Shareholders' Equity | 23.15M | 31.79M | 39.13M | 76.27M | 19.02M | |||
| TOTAL LIABILITIES AND EQUITY | 29.90M | 38.04M | 45.25M | 92.88M | 30.33M | |||
| Statistics | ||||||||
| Current Ratio | 4.43 | 6.09 | 7.39 | 5.55 | 2.71 | |||
| Return On Assets (ROA) | -82.94% | -57.66% | -86.81% | -41.37% | -99.37% | |||
| Return On Equity (ROE) | -107.09% | -69.00% | -100.38% | -50.37% | -158.46% | |||
All data in USD , ROIC based on taxRate of 0.21